$NURO
NeuroMetrix, Inc. Stock $nuro

$nuro Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-Q Financial Statement

#000162828019004677 Filed on April 25, 2019

Income Statement

Concept	2019 Q1	2018 Q1
Revenue	$3.123M	$4.943M
YoY Change	-36.82%	14.79%
Cost Of Revenue	$2.324M	$2.955M
YoY Change	-21.35%	9.55%
Gross Profit	$798.7K	$1.988M
YoY Change	-59.82%	18.98%
Gross Profit Margin	25.58%	40.21%
Selling, General & Admin	$3.645M	$4.309M
YoY Change	-15.41%	7.2%
% of Gross Profit	456.34%	216.77%
Research & Development	$855.1K	$1.280M
YoY Change	-33.17%	41.66%
% of Gross Profit	107.06%	64.37%
Depreciation & Amortization	$31.78K	$55.44K
YoY Change	-42.68%	-9.96%
% of Gross Profit	3.98%	2.79%
Operating Expenses	$4.500M	$5.588M
YoY Change	-19.48%	13.52%
Operating Profit	-$3.701M	-$3.601M
YoY Change	2.79%	8.64%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$20.00K	$10.00K
YoY Change	100.0%
Pretax Income	$2.050M	$1.170M
YoY Change	75.21%	-136.22%
Income Tax
% Of Pretax Income
Net Earnings	$2.051M	$1.166M
YoY Change	75.82%	-136.08%
Net Earnings / Revenue	65.66%	23.59%
Basic Earnings Per Share	$2.65	$0.18
Diluted Earnings Per Share	$1.47	$0.08
COMMON SHARES
Basic Shares Outstanding	774.1K shares	6.346M shares
Diluted Shares Outstanding	1.397M shares	13.73M shares

Balance Sheet

Concept	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.200M	$6.100M
YoY Change	18.03%	-11.59%
Cash & Equivalents	$7.201M	$6.100M
Short-Term Investments
Other Short-Term Assets	$960.0K	$950.0K
YoY Change	1.05%	-33.1%
Inventory	$2.494M	$1.859M
Prepaid Expenses
Receivables	$972.4K	$1.589M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$11.63M	$10.50M
YoY Change	10.78%	0.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$375.6K	$431.7K
YoY Change	-13.0%	-8.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$30.00K	$40.00K
YoY Change	-25.0%	-73.33%
Total Long-Term Assets	$2.277M	$474.8K
YoY Change	379.48%	-24.09%
TOTAL ASSETS
Total Short-Term Assets	$11.63M	$10.50M
Total Long-Term Assets	$2.277M	$474.8K
Total Assets	$13.91M	$10.97M
YoY Change	26.74%	-1.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$557.9K	$384.1K
YoY Change	45.25%	-4.95%
Accrued Expenses	$3.036M	$2.361M
YoY Change	28.59%	69.27%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.503M	$4.150M
YoY Change	8.49%	35.39%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.210M
YoY Change
Total Long-Term Liabilities	$1.210M	$0.00
YoY Change		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.503M	$4.150M
Total Long-Term Liabilities	$1.210M	$0.00
Total Liabilities	$5.714M	$4.150M
YoY Change	37.68%	28.22%
SHAREHOLDERS EQUITY
Retained Earnings	-$189.0M	-$189.9M
YoY Change	-0.49%	4.51%
Common Stock	$831.00	$714.00
YoY Change	16.39%	-18.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.192M	$6.823M
YoY Change
Total Liabilities & Shareholders Equity	$13.91M	$10.97M
YoY Change	26.74%	-1.05%

Cashflow Statement

Concept	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	$2.051M	$1.166M
YoY Change	75.82%	-136.08%
Depreciation, Depletion And Amortization	$31.78K	$55.44K
YoY Change	-42.68%	-9.96%
Cash From Operating Activities	$420.4K	$2.080M
YoY Change	-79.79%	-162.09%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$25.83K
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$25.83K
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$0.00	0.000
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	$420.4K	$2.080M
Cash From Investing Activities	$0.00	-$25.83K
Cash From Financing Activities	$0.00	0.000
Net Change In Cash	$420.4K	$2.054M
YoY Change	-79.54%	-30.37%
FREE CASH FLOW
Cash From Operating Activities	$420.4K	$2.080M
Capital Expenditures	$0.00	$25.83K
Free Cash Flow	$420.4K	$2.054M
YoY Change	-79.54%	-161.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	nuro	Technology Fees TechnologyFees	450000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1298084	USD
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001289850
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8820273	shares
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	NeuroMetrix, Inc.
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2019Q1	dei	Trading Symbol TradingSymbol	NURO
CY2018Q4	nuro	Accrued Compensation AccruedCompensation	213756	USD
CY2019Q1	nuro	Accrued Compensation AccruedCompensation	467522	USD
CY2018Q4	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	1101658	USD
CY2019Q1	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	726892	USD
CY2018Q1	nuro	Collaboration Income CollaborationIncome	4755705	USD
CY2019Q1	nuro	Collaboration Income CollaborationIncome	5734849	USD
CY2018Q4	nuro	Contract Manufacturer ContractManufacturer	160000	USD
CY2019Q1	nuro	Contract Manufacturer ContractManufacturer	320000	USD
CY2018Q4	nuro	Deferred Collaboration Income DeferredCollaborationIncome	1956522	USD
CY2019Q1	nuro	Deferred Collaboration Income DeferredCollaborationIncome	181818	USD
CY2018Q1	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-553439	USD
CY2019Q1	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-374766	USD
CY2019Q1	nuro	Operating Lease Discount OperatingLeaseDiscount	672354	USD
CY2019Q1	nuro	Operating Leases Future Minimum Payments Duein Seven Years OperatingLeasesFutureMinimumPaymentsDueinSevenYears	117431	USD
CY2019Q1	nuro	Operating Leases Future Minimum Payments Duein Six Years OperatingLeasesFutureMinimumPaymentsDueinSixYears	165785	USD
CY2019Q1	nuro	Restricted Cash Collateral Letters Of Credit RestrictedCashCollateralLettersOfCredit	226731	USD
CY2018Q4	nuro	Technology Fees TechnologyFees	450000	USD
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	557861	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1082957	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	972352	USD
CY2018Q4	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	171000	USD
CY2019Q1	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	61200	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2236633	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3036301	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	391000	USD
CY2019Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	863000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	197113646	USD
CY2019Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	197157649	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	341026	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	44093	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	USD
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	USD
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	796192	shares
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	947869	shares
CY2018Q4	us-gaap	Assets Assets	13991880	USD
CY2019Q1	us-gaap	Assets Assets	13906763	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	11586165	USD
CY2019Q1	us-gaap	Depreciation Depreciation	31778	USD
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2019Q1	us-gaap	Assets Current AssetsCurrent	11630142	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6780429	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7200795	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4043681	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6097792	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6780429	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7200795	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2054111	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	420366	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7380463	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8310463	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7380463	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8310463	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	738	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	831	USD
CY2018Q1	us-gaap	Cost Of Revenue CostOfRevenue	2955260	USD
CY2019Q1	us-gaap	Cost Of Revenue CostOfRevenue	2324231	USD
CY2018Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	297858	USD
CY2018Q1	us-gaap	Depreciation Depreciation	55444	USD
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2019Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	208741	USD
CY2019Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y9M05D
CY2018Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1804143	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1619490	USD
CY2018Q1	us-gaap	Gross Profit GrossProfit	1987730	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	798704	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-369665	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-740223	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-814108	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-110605	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-868	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	657059	USD
CY2018Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	USD
CY2019Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1774704	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-283909	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	182404	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-343177	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	101579	USD
CY2018Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	7380895	shares
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	6222746	shares
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1094190	USD
CY2019Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	783900	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	2861864	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	2494268	USD
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1767674	USD
CY2019Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1710368	USD
CY2018Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2019Q1	us-gaap	Inventory Write Down InventoryWriteDown	700000	USD
CY2018Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	156703	USD
CY2019Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	166024	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2464118	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	473413	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	165785	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	247347	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	653164	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	641193	USD
CY2018Q4	us-gaap	Liabilities Liabilities	7894069	USD
CY2019Q1	us-gaap	Liabilities Liabilities	5714352	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13991880	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13906763	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6592897	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4502872	USD
CY2019Q1	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2019-06-30
CY2019Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	2500000	USD
CY2019Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	2300000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25833	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2079944	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	420366	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	1166252	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	2050507	USD
CY2018Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1166252	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2050507	USD
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	5588448	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	4499859	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3600718	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3701155	USD
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	577460	USD
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	580284	USD
CY2018Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1301172	USD
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1211480	USD
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1968062	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1870979	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	143580	USD
CY2019Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	178295	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2018Q1	us-gaap	Other Income OtherIncome	11265	USD
CY2019Q1	us-gaap	Other Income OtherIncome	16813	USD
CY2018Q1	us-gaap	Other Operating Income OtherOperatingIncome	4766970	USD
CY2019Q1	us-gaap	Other Operating Income OtherOperatingIncome	5751662	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25833	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	860915	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	962727	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	30314	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	30081	USD
	us-gaap	Proceeds From Collaborators ProceedsFromCollaborators	18700000	USD
CY2018Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	129837	USD
CY2019Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	116000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	407339	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	375561	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1279564	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	855081	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-191016591	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-189000000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-188966084	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4942990	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3122935	USD
CY2018Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2504741	USD
CY2019Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2025288	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	341026	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	44093	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	5017389	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	6822524	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	6097811	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	8192411	USD
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13726614	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13964209	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6345719	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7741463	shares
CY2019Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior period amounts have been reclassified to conform to the current period presentation. </font></div></div>
CY2019Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-19-004677-index-headers.html	Edgar Link	pending
0001628280-19-004677-index.html	Edgar Link	pending
0001628280-19-004677.txt	Edgar Link	pending
0001628280-19-004677-xbrl.zip	Edgar Link	pending
a10q3312019document.htm	Edgar Link	pending
a10q3312019ex101.htm	Edgar Link	pending
a10q3312019ex311.htm	Edgar Link	pending
a10q3312019ex312.htm	Edgar Link	pending
a10q3312019ex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nuro-20190331.xml	Edgar Link	completed
nuro-20190331.xsd	Edgar Link	pending
nuro-20190331_cal.xml	Edgar Link	unprocessable
nuro-20190331_def.xml	Edgar Link	unprocessable
nuro-20190331_lab.xml	Edgar Link	unprocessable
nuro-20190331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NURO
NeuroMetrix, Inc. Stock $nuro

2019 Q1 Form 10-Q Financial Statement

#000162828019004677 Filed on April 25, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO NeuroMetrix, Inc. Stock $nuro

2019 Q1 Form 10-Q Financial Statement

#000162828019004677 Filed on April 25, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO
NeuroMetrix, Inc. Stock $nuro